Recruiting

Force Feedback

Sponsor:

Ohio State University

Code:

NCT07660900

Conditions

Lobectomy

Segmentectomy

Force Measurement

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during robotic-assisted surgery.

Conditions

Lobectomy

Segmentectomy

Force Measurement

Study ID

NCT07660900

Start date

Sep 5, 2025

Status verified date

Mar, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ages 18 years or older
  • Undergoing robotic-assisted anatomic lung resection (lobectomy or segmentectomy) at The Ohio State University Wexner Medical Center

Exclusion Criteria:

  • Age < 18 years old
  • Subject is pregnant or suspected to be pregnant or breastfeeding
  • ECOG Performance status > 2
  • Do not qualify for ERAS protocol
  • Undergoing an emergent procedure
  • Undergoing non-anatomic lung resection
  • Undergoing pneumonectomy
  • Previous ipsilateral thoracic surgery (open, video-assisted thoracoscopic or robotic)
  • Planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned
  • Non-English speaking

Study Design

Enrollment

270 participants

Anticipated

Interventions and Outcome Measures

Arms

da Vinci 5 Robotic Surgical System

da Vinci Xi Robotic Surgical System

Primary outcome measure

  • Textbook Recovery [ Time Frame: From surgery date to 30 days post-operative ]

Central Contacts and Locations

Locations

The James Cancer Hospital

Recruiting

Columbus, Ohio, United States, 43221

Contacts

Chandler Lowe

614-293-9955chandler.lowe@osumc.edu

Principal Investigator:

Peter Kneuertz, MD

More Information

Sponsor

Ohio State University

Last update posted

Jun 22, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ohio State University on 2026-06-22.